Waki Imoto

4PUBLICATIONS
12CO-AUTHORS
Medical infection agents (incl. prions)Condensed matter characterisation technique developmentHaematology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Jan 30, 2026
Efficacy of cefiderocol and levofloxacin against Stenotrophomonas maltophilia in a hemorrhagic pneumonia mouse model.

Waki Imoto, Junko Abe, Norihiro Sakurai

|Aug 01, 2024
Incidence and risk factors for coronavirus disease 2019-associated pulmonary aspergillosis using administrative claims data.

Waki Imoto, Yasutaka Ihara, Takumi Imai

|Mar 07, 2024
Evaluation of predictors of third-generation cephalosporin non-susceptibility and factors affecting recurrence or death in bacteremia caused by Citrobacter freundii complex, Enterobacter cloacae complex, and Klebsiella aerogenes.

Kazuhiro Kobayashi, Atsuko Hata, Waki Imoto

|Jun 15, 2022
Long COVID with intracranial microangiopathy.

W Imoto, K Yamada, H Kakeya

Pageof 1

Frequent Collaborators

2 joint publications

Hiroshi Kakeya

1 joint publications

Kazuhiro Kobayashi

1 joint publications

Atsuko Hata

1 joint publications

Shigeki Kakuno